Detalhe da pesquisa
1.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Oncologist
; 29(5): e622-e634, 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38175669
2.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36625938
3.
Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
Ann Surg Oncol
; 30(8): 4657-4668, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36809608
4.
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment.
Curr Opin Oncol
; 34(6): 635-642, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36000362
5.
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests.
Int J Mol Sci
; 23(21)2022 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36362392
6.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34875670
7.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33152285
8.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32404150
9.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Breast Cancer Res Treat
; 182(2): 401-409, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32500397
10.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
Breast Cancer Res Treat
; 184(2): 421-431, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32770287
11.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32501121
12.
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Lancet Oncol
; 20(10): 1360-1369, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31494037
13.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36809405
14.
ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
Ann Surg Oncol
; 30(9): 5705-5706, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36820935
15.
ASO Visual Abstract: Nonsentinel Axillary Lymph-Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph-Node-A Predictive Model Proposal.
Ann Surg Oncol
; 30(9): 5707-5708, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37405668
16.
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
Breast J
; 25(6): 1310-1311, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31338934
17.
Therapeutic resistance and optimal drug sequencing in HER2-positive metastatic breast cancer: unmet needs and future perspectives.
Heliyon
; 10(1): e23367, 2024 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38163142
18.
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.
Cells
; 13(7)2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38607036
19.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38447275
20.
Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer.
Cancer Treat Rev
; 112: 102496, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36563600